Category : Search result: Tildrakizumab


Sun Pharma's Ilumya for Psoriasis Launched in India

Sun Pharma introduces its global biologic Ilumya for moderate-to-severe plaque psoriasis in India. Backed by Phase-3 data, it offers long-lasting clearance with a strong safety profile. Learn more about this targeted therapy.

Page 1 of 1